<SEC-DOCUMENT>0001279569-20-000298.txt : 20200316
<SEC-HEADER>0001279569-20-000298.hdr.sgml : 20200316
<ACCEPTANCE-DATETIME>20200313195908
ACCESSION NUMBER:		0001279569-20-000298
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200311
FILED AS OF DATE:		20200316
DATE AS OF CHANGE:		20200313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		20714906

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD></HEAD>
<TITLE></TITLE>
<body>


<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>



<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT
OF 1934</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">For the month of March
2020.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Commission File Number 001-38496</P>



<P STYLE="font: 20pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 20pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Canopy Growth Corporation</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">(Translation of registrant&rsquo;s name
into English)&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1 Hershey Drive</B></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Smiths Falls, Ontario</B></P>

<P STYLE="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>K7A 0A8</B></P>

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive office)</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 30%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/13pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:</FONT><BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Form 20-F </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Form 40-F </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT></P>

<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Note</B>: Regulation S-T Rule 101(b)(1) only permits
the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): </FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Note</B>: Regulation S-T Rule 101(b)(7) only permits
the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer
must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized
(the registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s
securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed
to the registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission
or other Commission filing on EDGAR.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 0.75pt"><DIV STYLE="font-size: 1pt; border-top: gray 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Exhibit Index</B></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 86%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; border-bottom: black 1pt solid"><B>&nbsp;&nbsp;&nbsp;&nbsp;Exhibit&nbsp;No.&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
    <TD STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">
        <P STYLE="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0; border-bottom: black 1pt solid; margin-bottom: 0; text-align: center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Description&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex991.htm">Ex. 99.1</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex991.htm">News
    Release dated March 11, 2020 - Canopy Growth and TerrAscend Canada Enter Debt Financing Arrangement</A> </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/0.05pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 1pt 0in 1pt 0.75pt"><DIV STYLE="font-size: 1pt; border-top: gray 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 11.25pt 0 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 8pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse">
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.8pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 2.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CANOPY GROWTH CORPORATION</B></FONT></TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 11%; padding-right: 0.8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; padding-right: 0.8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 77%">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; border-bottom: black 0.75pt solid">/s/ Phil Shaer</P></TD>
    <TD STYLE="padding-bottom: 8pt; width: 11%; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">Phil Shaer</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0">Chief Legal Officer</P></TD>
    <TD STYLE="padding-bottom: 8pt; font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</TD></TR>
</TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Dated: March 11, 2020</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED MARCH 11, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth and TerrAscend Canada Enter
Debt Financing Arrangement</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth completes C$80.5 million loan
to TerrAscend Canada Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SMITHS FALLS, ON, March 11, 2020 /CNW/ -&nbsp;Canopy
Growth Corporation (&quot;Canopy Growth&quot; or the &quot;Company&quot;) (TSX:WEED, NYSE:CGC) and TerrAscend Canada Inc. (&quot;TerrAscend
Canada&quot;), a wholly owned subsidiary of TerrAscend Corp. (&quot;TerrAscend&quot;) (CSE:TER, OTCQX: TRSSF), today announced
they have entered into a loan financing arrangement in the amount of C$80.5 million (the &quot;Loan&quot;) pursuant to a secured
debenture (the &quot;Debenture&quot;). In connection with the Loan, TerrAscend has issued 17,808,975 common share purchase warrants
to the Company (the &quot;Warrants&quot;).</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth initially co-invested in TerrAscend
in November 2017. On November 30, 2018, Canopy Growth announced the completion of a restructuring transaction with TerrAscend pursuant
to which TerrAscend restructured its share capital by way of a plan of arrangement under the&nbsp;<I>Business Corporations Act&nbsp;</I>(Ontario).</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>&quot;</B>TerrAscend Canada&nbsp;has proven
its&nbsp;ability to thrive and this loan is a strong signal that Canopy Growth&nbsp;is confident in their ability to execute over
the long term,&quot; said David Klein, CEO, Canopy Growth. &quot;We are&nbsp;encouraged by TerrAscend's strong performance&nbsp;and
we view the team's experience as an important contributor to its continued&nbsp;success.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;We are pleased to receive this loan from
Canopy Growth as we enter into the next stage of TerrAscend's growth and expansion,&quot; said Jason Ackerman, Executive Chairman
and Interim CEO. &quot;We look forward to continuing to work with Canopy Growth as new opportunities emerge and the regulatory
landscape evolves.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Use of Proceeds</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The net proceeds are expected to be used by
TerrAscend Canada for general corporate purposes and the funding of its Canadian operations, its Arise Bioscience U.S. hemp division,
international expansion and the repayment of indebtedness. The funds cannot be used, directly or indirectly, in connection with
or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable
laws of the United States.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Transaction Overview </B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The Debenture will bear interest at a rate
of 6.10% per annum and will mature on March 10, 2030 or such earlier date in accordance with the terms of the Debenture and all
interest payments made pursuant to the Debenture are payable in cash by TerrAscend Canada. The Debenture is secured by the assets
of TerrAscend Canada, is not convertible and is not guaranteed by TerrAscend. The Warrants are comprised of 15,656,242 common share
purchase warrants (the &quot;First Tranche Warrants&quot;) with each First Tranche Warrant entitling Canopy Growth to acquire one
common share of TerrAscend at an exercise price of $5.14 per share, subject to adjustment in certain events and 2,152,733 common
share purchase warrants (the &quot;Second Tranche Warrants&quot;) with each Second Tranche Warrant entitling Canopy Growth to acquire
one common share of TerrAscend at an exercise price of $3.74 per share, subject to adjustments in certain events. The Warrants
will be exercisable by Canopy Growth following changes in U.S. federal laws permitting the cultivation, distribution and possession
of marijuana or to remove the regulation of such activities from the federal laws of the United States. The First Tranche Warrants
expire on March 10, 2030 or such earlier date in accordance with the First Tranche Warrants and the Second Tranche Warrants expire
on March 10, 2031 or such earlier date in accordance with the Second Tranche Warrants.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B>&nbsp;<BR>
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct
brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's
subsidiary, Storz &amp; Bickel GMbH &amp; Co. KG. From product and process innovation to market execution, Canopy Growth is driven
by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has operations in over a dozen countries across five continents.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth's medical division, Spectrum
Therapeutics, is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the
public's understanding of cannabis, and has devoted millions of dollars toward cutting-edge, commercializable research and IP development.
Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as
single cannabinoid Dronabinol under the brand Bionorica Ethics.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth operates retail stores across
Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large
and loyal following by focusing on quality products and meaningful customer relationships.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation
Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet
of production capacity, including over one million square feet of GMP certified production space. For more information visit <U>www.canopygrowth.com</U></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements<BR>
</B>This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities
Litigation Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities
legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any
future results, performance or achievements expressed or implied by the forward-looking statements or information contained in
this news release. Examples of such statements include statements with respect to the use of proceeds, management's belief of TerrAscend's
ability over the long term and the expectation that the Loan will enable TerrAscend to fund and execute on its Canadian, U.S. hemp
and international businesses. Risks, uncertainties and other factors involved with forward-looking information could cause actual
events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking
information, including regulatory and licensing risks, the ability of the Company to exercise the Warrants and the occurrence of
changes in U.S. federal laws regarding the cultivation, distribution or possession of marijuana, changes in the use of proceeds,
changes in general economic, business and political conditions, including changes in the financial and stock markets, the global
regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change, risks
relating to anti-money laundering laws, compliance with extensive government regulation and the interpretation of various laws,
regulations and policies, risk associated with divesting certain of investments, public opinion and perception of the cannabis
industry, and such risks contained in the public filings of the Company filed with Canadian securities regulators and available
on the&nbsp; issuer profile of the Company on SEDAR at www.sedar.com, including the Company's annual information form dated June
25, 2019. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking
statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be
given that such events will occur in the disclosed time frames or at all. The forward-looking information and forward-looking statements
included in this news release are made as of the date of this news release and the Company does not undertake any obligation to
publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-and-terrascend-canada-enter-debt-financing-arrangement-301021300.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/March2020/11/c4463.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Kyna Boyce, Media Relations, media@canopygrowth.com,
613-485-2480; Judy Hong, Vice President, Investor Relations (USA), Judy.hong@canopygrowth.com; Tyler Burns, Vice President, Investor
Relations (Canada), Tyler.burns@canopygrowth.com, 855-558-9333 ext. 122</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 11-MAR-20</P>



<P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></p>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "0 -L# 2(  A$! Q$!_\0
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H<L;*/3[2.VA+>7&,+N.3^=3XQ2T +1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
